News

HUMBL, Inc. Partners with MultiCortex to Revolutionize AI

HUMBL, Inc. Partners with MultiCortex to Revolutionize AI

HUMBL, Inc. Teams Up with MultiCortex to Enhance AI Solutions

HUMBL, Inc. is excited to share the news of a transformative joint venture with MultiCortex, LLC, an innovative leader in artificial intelligence and high-performance computing. This collaboration aims to redefine AI distribution across markets, enhancing the technology's accessibility and impact.

Key Details of the Joint Venture Agreement

In line with the terms of this agreement, HUMBL, Inc. will secure a 51% equity stake while MultiCortex co-founders Bruno Ghizoni and Alessandro Faria will maintain a 49% stake and handle daily operations. To fuel this initiative, HUMBL, Inc. will allocate up to $3 million USD from an impending Regulation A+ public offering to bolster their market strategies.

Innovative Solutions from MultiCortex

This partnership is crucial for the advancement of MultiCortex's proprietary platform, called the "Forest of Algorithms," which is designed to integrate various large language models (LLMs) into one cohesive system. Alessandro Faria, the CTO and one of the co-founders of MultiCortex, has been instrumental in developing this advanced platform, which NVIDIA has acknowledged for its innovative capabilities.

The Forest of Algorithms

The "Forest of Algorithms" enables the smooth orchestration of multiple LLMs, creating an intelligent framework that simplifies AI interactions. This sophisticated AI system will be made available globally through major cloud services such as AWS, Google Cloud, Oracle Cloud, and Microsoft Azure, ensuring extensive reach and application.

Leadership and Vision

Alessandro Faria brings extensive experience to this collaboration, having processed over 100 million biometric identities as a recognized figure in the biometric AI field. His prowess is complemented by MultiCortex's solid partnerships with AWS and Intel, fully positioning the company to provide cutting-edge AI solutions within various ecosystems.

Comments from Leadership

Thiago Moura, CEO of HUMBL, Inc., expressed enthusiasm about this joint venture, stating, "This venture allows us to take cutting-edge AI and deliver it globally through our commercial reach in the United States and Latin America. Together, the companies aim to shape the future of AI through an integrated, collaborative model that prioritizes interoperability over competition." This sentiment underlines the strategic imperative of ensuring that their AI solutions are not only innovative but also widely accessible.

Future Aspirations and Growth

Looking toward the future, the joint venture is set to bolster MultiCortex's sales, strategic partnerships, and financial frameworks within the U.S. marketplace. Additionally, the venture will focus on developing customized AI integrations tailored to enterprise clients, catering to specific needs and industry sectors.

About HUMBL, Inc.

HUMBL, Inc. is steering towards a shareholder value-centric approach under the guidance of CEO Thiago Moura, who is also the Principal of Ybyra Capital — a diversified Brazilian holding company that invests in sectors like commodities and mining. This unique structure of HUMBL, Inc. allows the formation of two-way distribution pipelines across the U.S. and Latin America, leveraging Ybyra Capital’s established presence to provide strategic partners with immediate access to burgeoning markets.

About MultiCortex, LLC

MultiCortex, LLC operates in both the U.S. and Brazilian markets, focusing on the development of sophisticated federated AI platforms. Founded by Bruno Ghizoni and Alessandro Faria, this company's flagship product, the Forest of Algorithms, is designed to unify multiple large language models into a single, powerful AI system. Faria's revolutionary work in biometric AI has previously processed millions of identities, positioning MultiCortex as a trusted entity in collaboration with AWS and Intel.

Frequently Asked Questions

What is the purpose of the joint venture between HUMBL and MultiCortex?

The joint venture aims to enhance AI solutions through the development and distribution of MultiCortex's "Forest of Algorithms" platform, integrating various AI systems.

How much will HUMBL invest in the joint venture?

HUMBL plans to invest up to $3 million USD from its upcoming Regulation A+ public offering to support the joint venture's initiatives.

What recognition has the Forest of Algorithms received?

The Forest of Algorithms has been recognized by NVIDIA for its innovation, showcasing its potential in advanced AI applications.

Who leads the operations of MultiCortex?

Bruno Ghizoni and Alessandro Faria, the co-founders, will manage the operations of MultiCortex within the joint venture.

What markets will benefit from this partnership?

This partnership will primarily benefit the U.S. and Latin American markets, allowing for broader access to cutting-edge AI solutions across these regions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 2

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Insightful Findings on gMG Treatments by UCB at AANEM 2024

Updated Category News Views 127

UCB Highlights Innovations in Generalized Myasthenia Gravis Treatments at AANEM 2024 UCB, a prominent global biopharmaceutical company, is gearing up to present its latest findings in the management of generalized myasthenia gravis (gMG) at the upcoming American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) meeting. The event, which will also feature...

Continue Reading
Lysander Funds Shares New Distributions Estimates for ETFs

Updated Category News Views 131

Lysander Funds Shares New Distributions Estimates Lysander Funds Limited recently made an announcement about the anticipated cash distributions for December 2024 for their exchange-traded funds (ETFs). The focus is on three notable ETFs: Lysander-Slater Preferred Share ActivETF, Lysander-Canso Corporate Treasury ActivETF, and Lysander-Canso Floating Rate ActivETF. Each of...

Continue Reading
Empowering Girls: Pace Center's Initiatives for Growth

Updated Category News Views 350

Introduction to the Capital Campaign Pace Center for Girls Hillsborough is excited to announce its capital campaign aimed at expanding its capacity and enhancing the support provided to girls in the community. Through dedicated efforts such as education, counseling, and training, this campaign signifies a crucial step towards bettering the future for girls in Hillsborough...

Continue Reading
Bank of America Sees Growth in Loans, Deposits Amid Profit Rise

Updated Category News Views 284

Bank of America Reports Increased Earnings and Efficiency Bank of America Corp (NASDAQ: BAC) has announced strong financial results for the second quarter, showcasing impressive growth in loans, deposits, and overall profitability. The bank reported a net income of $7.1 billion, a slight increase from $6.9 billion the previous year, along with an earnings per share (EPS)...

Continue Reading
Investigating Manitex International: A Closer Look at MNTX

Updated Category News Views 72

Examining Fair Treatment for Manitex International Shareholders Ademi LLP has launched an investigation into Manitex International, Inc. (NASDAQ: MNTX) due to concerns about possible breaches of fiduciary duty related to its recent transaction with Tadano. This investigation raises important questions about whether shareholders are being treated fairly in the financial...

Continue Reading